Pharmaceutical Executive Editorial Staff

Roku's Chris Schneider discusses how pharmaceutical marketers are still missing a huge population: the cord cutters.

Pfizer CEO Albert Bourla, Ph.D., is in trouble for "misleading" and "overly promotional" claims he made during a BBC interview late last year about their COVID-19 vaccine for younger kids, which was not approved at the time.

With biopharma sales and marketing changing faster than ever, it’s become crucial for brands to stay relevant with each new product launch. Christopher Price shares his point of view through the lens of 20 years of experience in the space.

Building on Morgan Health’s accountable care strategy, Dr. Pegus will help inform the team’s renewed focus on population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, particularly among diverse populations.

80% of Rx Patients Currently See Providers with Access to POC Media.

This is the intelligence company's fifth acquisition.

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

Healthcare marketing leader Lasso powers a unique endemic HCP campaign, reaching 70% more providers than the benchmark and fueling 30% lift in new prescription activity.

The partnership enables clinical trial sponsors to pressure test protocol designs with Savvy Cooperative patients through ProofPilot's digital protocol interface.

The move reflects Fingerpaint Group's commitment to innovate its capabilities as clients' needs evolve.

The scale up of omnichannel operations intends to create a more personalized experience across the globe.

Ten-year partnership will help Merck reduce operational costs, deliver value to patients, and optimize the healthcare professional and patient experience.

The honor recognizes agencies that have achieved significant growth over the past three years.

Schappell and Warker join social health company Health Union to accelerate innovation and position the company for exponential growth.

Industry veteran Helen Kim has joined long-standing out of home specialist agency EMC Outdoor as senior vice president of client services.

On the occasion of the German Pain Congress 2022 (Deutscher Schmerzkongress 2022) the CNS-specialist announces Change for Health campaign.

Rocket Pharmaceutical's CEO and CTO spoke with Pharm Exec about adding a new position to the company's C-suite.

The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy, market development capabilities, and patient engagement platforms.

Two additional leadership moves also strengthen management team.

Pharmaceutical Executive presents the 2022 APEX Awards, which is presented by a jury of HCPs for breakthroughs in pharmaceutical and healthcare marketing and communications.

Elevalt’s 4Ps proprietary algorithms are the culmination of 6 years of refining omnichannel execution and are the foundation of the company’s data-driven approach to commercialization.

Jay Duker, MD, spoke with Pharm Exec about advancements in ocular drug delivery.

Follows recent launch of DeepIntent's innovative "Patient Planner" to simplify audience creation and campaign activation.

Sharif has over a decade of experience working in the healthcare field.

New managing director Trevor Pill has been passed the company's helm from founder Karen Winterhalter.

Leo Tarkovsky brings more than 25 years of proven experience scaling companies in the healthcare space.

Under its Commercial License Agreement with OBT, Genmab will obtain the exclusive right to develop and commercialize novel antibody therapeutics utilizing OBT's novel, first-in-class IO antibody.

Fast-growing specialty pharma selects Veeva CRM and Veeva Vault PromoMats to build a unified foundation for commercial excellence.